Postprandial hypoglycaemia

3 trials MedDRA PT
3 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
ATC code not specified 2
H Endocrinology (ATC H) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 1 Phase I (Other): 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

1 trial
  • Recordati AG Commercial
    PASIREOTIDE DIASPARTATE; PLACEBO
    2023-505316-37-00 4 countries 2024 n=30 Orphan
    Ended

Phase I (Other)

2 trials
  • Recordati AG Commercial
    IMP not specified
    2024-519165-22-00 1 country 2025 n=40
    Ended
  • Recordati AG Commercial
    IMP not specified
    2025-521830-27-00 1 country n=40
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Recordati AG Commercial 3 Phase I (Other), Phase II 0
New trials by year
2024
1
2025
1
← All indication landscapes